INTIO is scheduled to exhibit and display the ClearStart•SVM™ across the U.S. and in Europe at select conferences, meetings, congresses and trade shows. See the Events page for a full list of “appearances.”
Morgan Nields, President and CEO of INTIO, will be at many of the scheduled stops. He’ll be available to talk about the applications of INTIO’s self-contained image analysis desktop workstation and discuss its many applications in the interventional oncology market.
Other members of the INTIO management team – Dave Gustafson PhD, VP of R&D and CTO; Phil Ives, Director of Sales; and Jorge Lopez, Director of Clinical Applications – will also be on hand through this “tour,” showcasing and demonstrating the innovation of ClearStart•SVM™, to physicians, technologists, surgeons and researchers in the field of interventional oncology.